Skip to main content
Lunai Bioworks Inc. logo

Lunai Bioworks Inc. — Investor Relations & Filings

Ticker · RENB ISIN · US29350E1047 US Professional, scientific and technical activities
Open in API
Filings indexed 580 across all filing types
Latest filing 2023-07-11 Delisting Announcement
Country US United States of America
Listing US RENB

About Lunai Bioworks Inc.

https://www.lunaibio.com

Lunai Bioworks Inc. is a pre-clinical stage biotechnology company that utilizes artificial intelligence for drug discovery and biodefense. The company focuses on pioneering safe and responsible generative biology to develop new therapies. By harnessing phenomics and AI, it aims to decode disease signals and translate them into treatments. Its proprietary Transformer Platform is designed to accelerate drug discovery processes. Lunai Bioworks develops medicines, diagnostics, and biodefense products, with a pipeline that includes programs for neurodegenerative conditions like Alzheimer's disease.

Recent filings

Filing Released Lang Actions
FORM 8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content specifically details a notice of deficiency from Nasdaq regarding the company's failure to meet the minimum bid price requirement for continued listing, and outlines the compliance periods and potential delisting process. This is a regulatory announcement about the company's listing status, not a full financial report or earnings release. The key section is 'Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing,' which matches the definition of a Delisting Announcement. The document is about the delisting notice and related compliance timeline, so the appropriate classification is DLST (Delisting Announcement). The document length is about 4938 characters, which is sufficient to contain substantive information rather than just a brief notice or link, confirming it is the announcement itself, not just a report publication announcement or regulatory filing fallback.
2023-07-11 English
FORM DEFA14A
Remuneration Information Classification · 100% confidence The document is titled 'FORM DEFA14A' and is identified as an amendment and supplement to a proxy statement for the Annual Meeting of Stockholders. It references the Securities Exchange Act of 1934 and Schedule 14A, which are related to proxy solicitation materials. The content discusses amendments to the proxy statement, quorum requirements, and voting instructions for the annual meeting. There is no financial data or earnings information, nor is it a full annual or interim report. The document is clearly a filing related to executive compensation and proxy solicitation materials, consistent with the DEFA14A form type, which corresponds to Remuneration Information filings.
2023-07-10 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 7, 2023, by Enochian Biosciences Inc. It reports an amendment and restatement of the company's bylaws, specifically lowering the quorum requirement for stockholder meetings. The document includes a description of the bylaw changes and references an attached exhibit of the amended bylaws. There are no financial statements or detailed financial data presented. The content focuses on corporate governance changes, specifically amendments to the bylaws, which is a management or board-related update. According to the filing definitions, announcements of changes in company governance documents such as bylaws fall under Board/Management Information (MANG). The document length is 4247 characters, which is relatively short but contains substantive information about board-level governance changes, not just an announcement of a report. Therefore, the appropriate classification is MANG with high confidence.
2023-07-10 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It details a private placement financing transaction including the issuance of shares and warrants, and the conversion of convertible notes into equity securities. The key content is about fundraising activities and changes in capital structure. There are no financial statements or comprehensive financial analysis typical of annual or interim reports. The document is not a proxy, earnings release, or management discussion. It is a regulatory filing reporting a material definitive agreement and unregistered sales of equity securities, which fits the category of Capital/Financing Update (CAP). The document length (7081 characters) and content confirm it is a substantive filing, not just an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2023-06-28 English
Director's Dealing 2023
Director's Dealing
2023-06-28 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 20, 2023, by Enochian Biosciences Inc. It details the entry into a material definitive agreement with Lincoln Park Capital Fund, LLC, specifically a purchase agreement for the sale of common stock. The content focuses on the terms of this financing agreement, including share purchase rights, pricing, and registration rights. There are no financial statements or quarterly/yearly financial results presented, nor is this a transcript, proxy, or governance document. The primary subject is an update on a capital raising transaction. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is substantial (over 14,000 characters), and it contains detailed terms of the financing agreement, not just an announcement or summary, supporting a high confidence classification.
2023-06-26 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.